Denis Kuleshov

Denis Kuleshov

WarningWarningThis profile has not been verified yet. Information presented here may thus be incomplete or inaccurate.WarningWarning

Denis Kuleshov began working in the field of assistive technology in 2010, at Bauman Moscow State Technical University's Centre for Hearing Impaired People (GUIMC). He began as a laboratory assistant, then was promoted to training master, and currently works for the GUIMC as the head of the laboratory of accessible ICT and also as a senior lecturer where he teaches inclusive groups. Together with his partners, in 2015, Kuleshov founded the autonomous non-profit organization, the 'Centre for the Development of Social Innovation' "Technology of Opportunities," where he also currently works as the Director for Science and Innovation. At this Centre, he oversees research, scientific, and educational projectsfor the inclusion and rehabilitation of people with disabilities. Since 2017, Kuleshov has been working as the Director for the ANO Sensor-Tech Laboratory, which was established by the So-Yedinenie Charity Foundation for the Support of the Deaf-Blind. The goal of the this Laboratory is to develop both new technologies and new products for individuals both in Russia and abroad with hearing and vision impairments, including the deaf-blind. In July 2017, employees of the Laboratory and partners organized the first operations to install visual prosthetic systems (bionic vision) for deaf-blind patients in Russia. Sensor-Tech Laboratory has developed and produced advanced technological assistive devices, such as: Robin Smart Assistant for the Blind, the Charlie Speech Recognition Device, and is currently implementing a project to develop an ELVIS line of neuroimplants, for example: ELVIS V is a neuroimplant to the brain which restores lost visual functioning in both blind and deaf-blind people. ELVIS C is an implant which stimulates the auditory nerve in order to compensate for neurosensory hearing loss. ELVIS DBS is a neuroimplant designed to treat serious neurological diseases.